Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/162879
Title: Clinical Aspergillus signatures in COPD and bronchiectasis
Authors: Tiew, Pei Yee
Thng, Kai Xian
Chotirmall, Sanjay Haresh
Keywords: Science::Medicine
Issue Date: 2022
Source: Tiew, P. Y., Thng, K. X. & Chotirmall, S. H. (2022). Clinical Aspergillus signatures in COPD and bronchiectasis. Journal of Fungi, 8(5), 480-. https://dx.doi.org/10.3390/jof8050480
Project: SRG-OPN-06-2021
MOH-000710
Journal: Journal of Fungi
Abstract: Pulmonary mycoses remain a global threat, causing significant morbidity and mortality. Patients with airways disease, including COPD and bronchiectasis, are at increased risks of pulmonary mycoses and its associated complications. Frequent use of antibiotics and corticosteroids coupled with impaired host defenses predispose patients to fungal colonization and airway persistence, which are associated with negative clinical consequences. Notably, Aspergillus species remain the best-studied fungal pathogen and induce a broad spectrum of clinical manifestations in COPD and bronchiectasis ranging from colonization and sensitization to more invasive disease. Next-generation sequencing (NGS) has gained prominence in the field of respiratory infection, and in some cases is beginning to act as a viable alternative to traditional culture. NGS has revolutionized our understanding of airway microbiota and in particular fungi. In this context, it permits the identification of the previously unculturable, fungal composition, and dynamic change within microbial communities of the airway, including potential roles in chronic respiratory disease. Furthermore, inter-kingdom microbial interactions, including fungi, in conjunction with host immunity have recently been shown to have important clinical roles in COPD and bronchiectasis. In this review, we provide an overview of clinical Aspergillus signatures in COPD and bronchiectasis and cover the current advances in the understanding of the mycobiome in these disease states. The challenges and limitations of NGS will be addressed.
URI: https://hdl.handle.net/10356/162879
ISSN: 2309-608X
DOI: 10.3390/jof8050480
Rights: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:LKCMedicine Journal Articles

Files in This Item:
File Description SizeFormat 
Clinical Aspergillus Signatures in COPD and Bronchiectasis.pdf769.01 kBAdobe PDFView/Open

SCOPUSTM   
Citations 50

2
Updated on Dec 3, 2022

Web of ScienceTM
Citations 50

2
Updated on Dec 4, 2022

Page view(s)

9
Updated on Dec 5, 2022

Download(s)

3
Updated on Dec 5, 2022

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.